Clinical Trial Update: Amphotericin Versus Posaconazole for Pulmonary Mucormycosis [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial comparing amphotericin B with posaconazole for pulmonary mucormycosis is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Mucormycosis

Drugs mentioned

• Amphotericin B (Amphotericin B)
• POSACONAZOLE (POSACONAZOLE)

Snippet

Sponsor: Post Graduate Institute of Medical Education and Research, Chandigarh | Conditions: Mucormycosis; Pulmonary (Etiology) | Phase 2 | Status: RECRUITING